UHAL(UHAL)
UHAL
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $6.31B | $6.64B |
| Low | $6.21B | $6.48B |
| High | $6.39B | $6.80B |
| EBITDA Avg | $2.17B | $2.28B |
| Low | $2.13B | $2.23B |
| High | $2.20B | $2.33B |
| EBIT Avg | $1.18B | $1.24B |
| Low | $1.16B | $1.21B |
| High | $1.20B | $1.27B |
| Net Income Avg | $220M | $424M |
| Low | $220M | $411M |
| High | $228M | $427M |
| EPS Avg | $1.14 | $2.14 |
| Low | $1.12 | $2.10 |
| High | $1.16 | $2.18 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $1.79B | $1.49B | $1.34B | $1.74B | $1.84B | $1.52B | $1.37B |
| Low | $1.78B | $1.49B | $1.34B | $1.73B | $1.83B | $1.52B | $1.36B |
| High | $1.80B | $1.50B | $1.35B | $1.74B | $1.84B | $1.53B | $1.37B |
| EBITDA Avg | $615M | $513M | $462M | $597M | $631M | $523M | $469M |
| Low | $613M | $511M | $460M | $595M | $628M | $521M | $467M |
| High | $617M | $514M | $464M | $599M | $633M | $525M | $471M |
| EBIT Avg | $335M | $279M | $252M | $325M | $344M | $285M | $256M |
| Low | $334M | $278M | $251M | $324M | $342M | $284M | $255M |
| High | $336M | $280M | $253M | $326M | $345M | $286M | $257M |
| Net Income Avg | $142M | $18M | $-83M | $173M | $192M | $57M | $-53M |
| Low | $142M | $18M | $-83M | $172M | $191M | $57M | $-53M |
| High | $143M | $18M | $-83M | $173M | $193M | $57M | $-53M |
| EPS Avg | $0.73 | $0.09 | $-0.42 | $0.88 | $0.98 | $0.29 | $-0.27 |
| Low | $0.72 | $0.09 | $-0.43 | $0.88 | $0.98 | $0.29 | $-0.27 |
| High | $0.73 | $0.09 | $-0.42 | $0.88 | $0.98 | $0.29 | $-0.27 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |